Cherokees deserve help, treatment and hope – especially those who’ve long felt unseen by the health care system due to their ...
Eponyms — diseases named after a person — can cause serious confusion. That is particularly true in one rare disease ...
By Dr. Kaushik Mandal Rare diseases very often remain in the shadows, as common people have limited awareness about them.
Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical ...
In a new study, a team of researchers, including Anneliene Jonker, has published, in Nature Reviews Drug Discovery, the first ...
Ibuprofen counters problems caused by mutations in the MAN1B1 gene, fruit fly tests show. Early results in three children are ”fairly positive.” ...
Arrowhead Pharmaceuticals has begun laying the groundwork for its entry into a rare disease market, kicking off an awareness ...
Roughly one out of every ten people in the United States are affected by rare diseases. Many of these conditions are life‑threatening, and most ...
Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.
While PH Awareness Month is a great opportunity to connect and educate, rare disease advocacy is columnist Jen Cueva's passion all year.
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on BioCryst (BCRX – Research Report), with a price ...
About 7,000 identified rare diseases impact approximately 1 in 10 Oklahomans. The Cherokee Nation's first Rare Disease Summit ...